Inicio › Carcinoma de células escamosas de cabeza y cuello › Arkansas
Ensayos clínicos de Carcinoma de células escamosas de cabeza y cuello en Arkansas
10 estudios sobre Carcinoma de células escamosas de cabeza y cuello buscan participantes en Arkansas.
Ciudades en Arkansas
Texto oficial del estudio (inglés)
Testing the Addition of Anti-Cancer Drug, Cetuximab, to Standard of Care Treatment (Pembrolizumab) for Returning or Spreading Head and Neck Cancer After Previous Treatment
- University of Arkansas for Medical Sciences, Little Rock
ReclutandoFase 3
Edades de 18 en adelante · Todos los sexos · Actualizado el 30 sept 2026 · NCT06589804BiCaZO: A Study Combining Two Immunotherapies (Cabozantinib and Nivolumab) to Treat Patients With Advanced Melanoma or Squamous Cell Head and Neck Cancer, an immunoMATCH Pilot Study
- University of Arkansas for Medical Sciences, Little Rock
ReclutandoFase 2
Edades de 18 en adelante · Todos los sexos · Actualizado el 25 sept 2026 · NCT05136196Testing What Happens When an Immunotherapy Drug (Pembrolizumab) is Given by Itself Compared to the Usual Treatment of Chemotherapy With Radiation After Surgery for Recurrent Head and Neck Squamous Cell Carcinoma
- University of Arkansas for Medical Sciences, Little Rock
ReclutandoFase 2
Edades de 18 a 79 · Todos los sexos · Actualizado el 22 sept 2026 · NCT04671667Candida Therapeutic Vaccine in Head and Neck Cancer Patients to Reduce Recurrence
- Highlands Oncology Group, PA, Fayetteville
- University of Arkansas for Medical Sciences, Little Rock
- Highlands Oncology Group, PA, Rogers
- y 1 más
ReclutandoFase 2
Edades de 18 a 100 · Todos los sexos · Actualizado el 15 sept 2026 · NCT05952934Radiation Therapy With or Without Cisplatin in Treating Patients With Stage III-IVA Squamous Cell Carcinoma of the Head and Neck Who Have Undergone Surgery
- Mercy Hospital Fort Smith, Fort Smith
- CARTI Cancer Center, Little Rock
ReclutandoFase 2
Edades de 18 en adelante · Todos los sexos · Actualizado el 14 sept 2026 · NCT02734537ADCE-T02, a Tissue Factor Targeted Antibody-Drug Conjugate, in Patients With Selected Advanced Solid Tumours
- Highlands Oncology Group, Rogers
ReclutandoFase 1
Edades de 18 en adelante · Todos los sexos · Actualizado el 9 sept 2026 · NCT06597721Testing the Addition of the Drug BMX-001, a Radioprotector, or a Placebo to the Usual Chemoradiation Therapy for Patients With Head and Neck Cancer
- NEA Baptist Memorial Hospital and Fowler Family Cancer Center - Jonesboro, Jonesboro
ReclutandoFase 2
Edades de 18 en adelante · Todos los sexos · Actualizado el 17 ago 2026 · NCT06532279Comparing Sentinel Lymph Node (SLN) Biopsy With Standard Neck Dissection for Patients With Early-Stage Oral Cavity Cancer
- University of Arkansas for Medical Sciences, Little Rock
ReclutandoFase 2/3
Edades de 18 en adelante · Todos los sexos · Actualizado el 17 ago 2026 · NCT04333537A Study of Sigvotatug Vedotin in Advanced Solid Tumors
- Highlands Oncology Group, Fayetteville
- Highlands Oncology Group, Rogers
- Highlands Oncology Group, Springdale
ReclutandoFase 1
Edades de 18 en adelante · Todos los sexos · Actualizado el 6 jul 2026 · NCT04389632A Study of Dostarlimab vs Placebo After Chemoradiation in Adult Participants With Locally Advanced Unresected Head and Neck Squamous Cell Carcinoma
- GSK Investigational Site, Jonesboro
ReclutandoFase 3
Edades de 18 en adelante · Todos los sexos · Actualizado el 26 may 2026 · NCT06256588De ClinicalTrials.gov, datos obtenidos el 1 oct 2026. Cada estudio establece sus propios criterios de elegibilidad; el equipo del estudio decide quién puede participar.